Author: Lutz Weber

Dec. 7, 2021 Anixa Biosciences, Inc. (NASDAQ: ANIX), a biotechnology company focused on the treatment and prevention of cancer and infectious […]

TUBE Pharmaceuticals GmbH in Vienna, Austria, has developed cytotoxic molecules that are derived from a class of natural products called […]

MolGenie has currently been assigned the rights to develop and commercialize the rights to a EU-PCT patent application claiming treatments […]

HALLE (SAALE), Germany, May 7, 2021 /PRNewswire/ — OntoChem GmbH, a German Life Science IT company, announced today that it has assigned its drug […]